Acute Myeloid Leukemia
Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
Published in Oncology Business Week, June 8th, 2008
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) announced the initiation of the REVEAL-1 (Response Evaluation of Voreloxin in Elderly AML) Phase 2 clinical trial of voreloxin (also known as SNS-595), the company's lead anti-cancer therapeutic. The REVEAL-1 trial is being conducted in previously untreated elderly patients with acute myeloid leukemia (AML) who are unlikely to benefit from standard induction therapy. The first patient was enrolled and treated at the Indiana University Melvin and Bren Simon Cancer Center under the care of Larry D. Cripe, M.D., Associate Professor, Department of Medicine, Division of Hematology/Oncology at the Indiana University School of Medicine.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Abraxis BioScience, Inc.
Abraxis BioScience Reports 14% Revenue Growth to $82.1 Million for the First Quarter of 2008 - Abraxis BioScience, Inc.
New Data Highlighting the Potential Utility of ABRAXANE in Combination with Targeted Therapies and Other Chemotherapeutic Agents to Be Presented at ASCO - ActiveStrategy, Inc.
Oakwood Healthcare System Selects ActiveStrategy for Balanced Scorecard Software, Consulting - Adenocarcinoma Genetics
Scientists at Memorial Sloan Kettering Cancer Center, Department of Pathology publish new data on adenocarcinoma genetics - Advaxis, Inc.
Advaxis Files Investigational New Drug Application with U.S. Food and Drug Administration - Adverse Drug Reactions
Bayer Announces Availability of Reformulated Liquid Leukine(R) - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
